advertisement
Abstract #19671 Published in IGR 9-4
Prevalence of CYP1B1 mutations in Australian patients with primary congenital glaucoma
Dimasi DP; Hewitt AW; Straga T; Pater J; Mackinnon JR; Elder JE; Casey T; Mackey DA; Craig JEClinical Genetics 2007; 72: 255-260
Analysis of CYP1B1 in primary congenital glaucoma (PCG) patients from various ethnic populations indicates that allelic heterogeneity is high, and some mutations are population specific. No study has previously reported the rate or spectrum of CYP1B1 mutations in Australian PCG patients. The aim of this study is to determine the frequency of CYP1B1 mutations in our predominately Caucasian, Australian cohort of PCG cases. Thirty-seven probands were recruited from South-Eastern Australia, along with 100 normal control subjects. Genomic DNA was extracted and the coding regions of CYP1B1 analysed by direct sequencing. Sequence analysis identified 10 different CYP1B1 disease-causing variants in eight probands (21.6%). Five subjects were compound heterozygotes, two subjects heterozygous and one homozygous for CYP1B1 mutations. Three missense mutations are novel (D192Y, G329D, and P400S). None of the novel mutations identified were found in normal controls. One normal control subject was heterozygous for the previously reported CYP1B1 R368H mutation. Six previously described probable polymorphisms were also identified. Mutations in CYP1B1 account for approximately one in five PCG cases from Australia. Our data also supported the high degree of allelic heterogeneity seen in similar studies from other ethnic populations, thereby underscoring the fact that other PCG-related genes remain to be identified.
Dr. J. Craig, Department of Ophthalmology, Flinders University, Flinders Medical Centre, Bedford Park, Adelaide, SA 5042, Australia. Jamie.craig@flinders.edu.au
Classification:
1.2 Population genetics (Part of: 1 General aspects)
9.1.1 Congenital glaucoma, Buphthalmos (Part of: 9 Clinical forms of glaucomas > 9.1 Developmental glaucomas)
